Janssen signs deal with rising star Forma
January 11, 2012Research and Development Forma, Janssen, alliance
Janssen has signed a deal with Forma Therapeutics to discover, and develop drugs that target tumour metabolism mechanisms.Forma focuses on …
Richard Barker joins Aegate as a senior advisor
January 11, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aegate, Richard Barker
Aegate’s board of directors have announced that the previous director general of the ABPI has joined the company as a …
Sanofi to collaborate with UCSF on diabetes research
January 11, 2012Research and Development RNA interference, Sanofi, UCSF, academic alliance, diabetes
The University of California, San Francisco (UCSF) and Sanofi are to launch a new collaboration in diabetes research, focusing on …
Allergan plans $350m expansion of Irish plant
January 10, 2012Manufacturing and Production Allergan, Ireland
Allergan has announced plans to invest $350 million in an expansion of its manufacturing facility in County Mayo, Ireland, a …
Underwhelming results for GSK’s Relovair
January 10, 2012Research and Development, Sales and Marketing Advair, COPD, GSK, Relovair, Seretide, asthma
GlaxoSmithKline says it is on track to file its respiratory drug Relovair in Europe and the US despite mixed results …
NICE set to reject Xarelto in AF
January 10, 2012Sales and Marketing AF, NICE, Pradaxa, Xarelto, atrial fibrillation
NICE says it needs more data on Bayer’s Xarelto in order to recommend it for people with atrial fibrillation. The …
USP takes aim at supply chain security for medicines
January 10, 2012Manufacturing and Production US Pharmacopoeial Convention, USP, supply chains
The US Pharmacopoeial Convention (USP) has published the draft of a new general chapter designed to lay out best practices …
Scientists make drug delivery smooth as silk
January 10, 2012Manufacturing and Production Silk, manufacturing, microneedles
Researchers in the US have developed a new drug delivery system based on silk, which could allow drugs and vaccines …
Andrew Roberts joins Apodi senior management team
January 10, 2012Business Services, Sales and Marketing Andrew Roberts
Apodi has bolstered its senior management team with the arrival of Andrew Roberts as director of Business and Partnership Development. …
Study supports GLP-1 agonists for weight loss
January 10, 2012Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Sanofi, diabetes, lilly
An independent study by academics has concluded that GLP-1 agonist drugs help patients to lose weight – with the effect …
Shire signs strategic partnership deal with ICON
January 10, 2012Research and Development ICON, Shire
Contract research organisation ICON has signed a strategic partnership with Shire Specialty Pharmaceuticals to be the sole global provider of …
BMS to buy hep C firm Inhibitex for $2.5 billion
January 9, 2012Research and Development, Sales and Marketing BMS, Inhibitex, hep C
Bristol-Myers Squibb will acquire virology specialist Inhibitex for $2.5 billion, expanding its infectious disease portfolio. Bristol-Myers Squibb will acquire the …
AstraZeneca leaks confidential information
January 9, 2012Sales and Marketing AstraZeneca, data leak
There have been red faces at AstraZeneca after the company sent confidential information to analysts by mistake. It was forced …
Novartis recalls products as GMP issues close OTC facility
January 9, 2012Manufacturing and Production FDA, Novartis, OTC
Novartis has revealed that it is temporarily shutting down a manufacturing facility in Nebraska, US, and recalling four products as …
J&J to pay $1 billion for Risperdal charges
January 9, 2012Sales and Marketing J&J, JJ, Janssen, Risperdal
Johnson & Johnson will pay more than $1 billion in the US to resolve a civil investigation into the marketing …
Celgene appoints Dr David Gillen as its UK and Ireland medical director
January 9, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Celgene
Celgene has appointed former Pfizer man Dr David Gillen as its new UK and Ireland medical director. Gillen brings much …
Hospira faces lawsuits from disgruntled investors
January 9, 2012Manufacturing and Production Hospira, generics, manufacturing
Angry investors in US generic drugmaker Hospira have filed a class action lawsuit against the company, alleging that it misled …
Merck chief defends ‘bumpy’ 2011
January 6, 2012Sales and Marketing Kenneth Frazier, Merck
Kenneth Frazier has defended his company’s ‘bumpy’ performance in 2011, and has highlighted key drugs for investors to watch. Frazier …
2011 Year In Review
January 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Europe, emerging markets, year in review
A round up of some of the key themes in pharma’s yearEUROPE IN CRISIS While the Eurozone has averted meltdown …
New requirements for the technical validations of Marketing Authorisation Applications
January 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The current EU- eCTD v3.1 validation criteria came into force on 1st September 2011 for the technical validation for all …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
